Evaluation of the Effects of Intraoperative Ventilation Modes on Perioperative Atelectasis
Atelectasis, Postoperative Pulmonary
Bottom Line
View on ClinicalTrials.gov: NCT07413575 ↗Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- Female
- Sponsor
- Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
- Primary completion
- Jun 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Lung Ultrasound Score (ΔLUS) From Preoperative Baseline to 24 Hours Postoperatively |
4.92; 3.88; 5.20 | 0.131 |
| SECONDARY Mechanical Power During Intraoperative Ventilation |
7.05; 6.48; 6.47; 7.00; 6.03; 6.24 | — |
| SECONDARY Arterial Oxygen Partial Pressure (PaO₂) |
91.64; 90.96; 90.28; 101.08; 87.88; 85.28 | — |
| SECONDARY PaO₂/FiO₂ Ratio |
435.96; 432.76; 429.48; 480.84; 417.88; 405.6 | — |
Summary
Eligibility Criteria
Inclusion Criteria
Patients aged 45 years and older scheduled for hysterectomy surgery with an expected operative duration of more than 2 hours
Patients classified as American Society of Anesthesiologists (ASA) Physical Status Class I, II, or III
Patients for whom planned total intravenous anesthesia was preferred
Exclusion Criteria
Patients younger than 45 years
Patients planned for postoperative intensive care unit monitoring
Patients unable to provide written informed consent
Patients classified as American Society of Anesthesiologists Physical Status Class IV or higher
Patients with a body mass index (BMI) greater than 35
Patients who did not consent to participate in the study
Patients with neuromuscular diseases
Patients with uncontrolled asthma
Patients with chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung Disease (GOLD) Class IV
Patients with scoliosis
Patients with a history of pulmonary resection
Patients with chest wall deformities
Patients with a history of spontaneous pneumothorax
Patients for whom inhalational anesthesia was preferred
Data sourced from ClinicalTrials.gov (NCT07413575). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.